Originally published In Press as doi:10.1074/jbc.M205274200 on October 1, 2002
J. Biol. Chem., Vol. 277, Issue 49, 46891-46899, December 6, 2002
Heteromultimerization Modulates P2X Receptor Functions through
Participating Extracellular and C-terminal Subdomains*
Taka-aki
Koshimizu
§,
Susumu
Ueno¶,
Akito
Tanoue
,
Nobuyuki
Yanagihara¶,
Stanko S.
Stojilkovic
, and
Gozoh
Tsujimoto
**
From the
Department of Molecular and Cell
Pharmacology,
Endocrinology and Reproduction Research
Branch, NICHD, National Institutes of Health,
Bethesda, Maryland 20892 and the ¶ Department of
Pharmacology, University of Occupational and Environmental Health,
Japan School of Medicine, Tokyo 154-8567, Japan
Received for publication, May 29, 2002, and in revised form, September 16, 2002
 |
ABSTRACT |
P2X purinergic receptors (P2XRs) differ among
themselves with respect to their ligand preferences and channel
kinetics during activation, desensitization, and recovery. However, the
contributions of distinct receptor subdomains to the subtype-specific
behavior have been incompletely characterized. Here we show that
homomeric receptors having the extracellular domain of the
P2X3 subunit in the P2X2a-based backbone
(P2X2a/X3ex) mimicked two intrinsic functions
of P2X3R, sensitivity to 
-methylene ATP and
ecto-ATPase-dependent recovery from endogenous
desensitization; these two functions were localized to the N- and
C-terminal halves of the P2X3 extracellular loop,
respectively. The chimeric P2X2aR/X3ex
receptors also desensitized with accelerated rates compared with native
P2X2aR, and the introduction of P2X2 C-terminal
splicing into the chimeric subunit (P2X2b/X3ex) further increased the rate of desensitization. Physical and functional heteromerization of native P2X2a and P2X2b
subunits was also demonstrated. In heteromeric receptors, the
ectodomain of P2X3 was a structural determinant for ligand
selectivity and recovery from desensitization, and the C terminus of
P2X2 was an important factor for the desensitization rate.
Furthermore, [
-32P]8-azido ATP, a photoreactive
agonist, was effectively cross-linked to P2X3 subunit in
homomeric receptors but not in heteromeric P2X2 + P2X3Rs. These results indicate that heteromeric receptors formed by distinct P2XR subunits develop new functions resulting from
integrative effects of the participating extracellular and C-terminal subdomains.
 |
INTRODUCTION |
ATP and other purine nucleotides have widespread and potent
extracellular actions on excitable and non-excitable membranes. Synaptic and hormonal messenger functions of extracellular purine nucleotides are mediated by two types of cell-surface P2 purinergic receptors (1). The P2X receptors
(P2XRs)1 are ligand-gated
channels selectively permeable to cations, and the P2Y receptors are
members of G protein-coupled heptahelical receptor superfamily (2). In
addition to the fast excitatory synaptic signaling, P2XRs participate
in control of slower biological processes, including smooth and cardiac
muscle contraction, exocytosis, and blood cell functions (3-6). These
cellular processes depend on calcium ions as a critical intracellular
messenger. Activation of P2XRs leads to an increase in intracellular
free calcium concentration ([Ca2+]i) indirectly,
through depolarization of plasma membrane and activation of
voltage-dependent Ca2+ influx, in addition to
Ca2+ entry through the pores of P2XRs (7). The
cation-conducting pore of P2XRs is formed through multimerization of at
least three subunits (8). Versatile expression patterns of seven P2X
subunits identified so far (9) and their combinations through
heteromeric multimerization in a single cell account for
channel-specific calcium signaling patterns. Further diversity is
produced by alternative splicing of primary transcript for some
subunits, including P2X2 (10-12). Finally, the active
duration of ATP, a common agonist for P2XR, is under the control of
tissue-specific ecto-ATPase activity, and modification of ATP analogs
by this enzyme at the triphosphate moiety can severely influence the
agonistic potencies (9).
The P2XR subunits are composed of two putative transmembrane domains
critical for ion permeability, a large extracellular loop, and with N
and C termini in cytoplasmic face (9). The identification of cDNAs
for P2XR subunits in rat vas deferens and PC12 cells was followed by
the discovery of additional subunit members and homologs in divergent
mammalian species (2, 13). Their primary amino acid sequences exhibit a
strong degree of conservation, especially within the extracellular
regions. Ten cysteines in the extracellular region are well conserved,
and sulfhydryl bonds are proposed to connect these cysteines (2). Recently, residues critical for ATP binding were localized in the
extracellular loop near the first transmembrane domain of rat
P2X2Rs and at the well conserved lysine residue of
P2X1R (14, 15). These data confirmed that ATP interacts
with the extracellular part of P2XR to induce conformational changes
needed for receptor activation.
Recombinant P2XRs are divided into two groups according to their
relative potency for ATP and its analog 
-methylene-ATP (
-meATP). P2X1R and P2X3R exhibit high
sensitivity for both ligands and rapidly desensitize, whereas ATP is
more potent than 
-meATP in other receptors, including
P2X2R, P2X4R, and P2X7R, and
generates slow or non-desensitizing Ca2+ signals (2, 16).
The heteromeric assembly of two subunits, P2X2 and
P2X3, in sensory neurons results in a slow desensitizing channel that is sensitive to 
-meATP (17, 18).
Heteromultimerization of P2X4/P2X6 subunits and
P2X1/P2X5 subunits is also functionally distinguished (19, 20). Furthermore, the intracellular subunit regions
have modulatory effects on channel behavior, especially in controlling
the rate of receptor desensitization. For example, a C-terminal
deletion by alternative splicing and substitution of threonine at the N
terminus individually accelerate desensitization of P2X2Rs
(11, 12, 21-23).
However, the contributions of other receptor subdomains to the
generation of subtype-specific ligand selectivity and
activation/desensitization properties have been incompletely
characterized. Also, the effects of mutual interactions among different
receptor subdomains on the overall channel activity have not been
clarified. Here we studied a functional consequence of altering the
C-terminal and extracellular structures of P2XRs, in terms of agonist
sensitivity, time course of receptor desensitization, and recovery from
desensitization. To this end, we used extracellular chimeric mutants
between P2X2 and P2X3 subunits with full-length
or spliced P2X2 C terminus. The results of these
investigations revealed an additive effect of intracellular and
extracellular parts of P2XR subunits in regulating desensitization of homomeric and heteromeric receptors.
 |
EXPERIMENTAL PROCEDURES |
Construction of Chimeric Subunits--
Domain swapping between
P2X2 and P2X3 subunits was conducted using the
PCR-based overlap extension method as described by Horton et
al. (24). To swap the extracellular domains, SacI and
EcoRI sites were introduced into the coding sequences of
P2X2 and P2X3 subunits. The PCR primers with
silent nucleotide substitutions (underlined) are listed as
follows: X2EcoL, 5'-AACATCGATTCGAATTCCATAGGCTTTGAT-3'; X3SacU, 5'-ATTGAGAGCTCAGTAGTTACAAAGGTG-3'; X3SacL,
5'-GCTCTCAATGGCGGTGTCCCTCACTTG-3'; X3EcoU,
5'-GGAATTCGCTTTGATGTGCTGGTA-3'; and X3EcoL,
5'-GCGAATTCCAAAAGCCTTCAGGAGTGT-3'. The
intrinsic SacI site located in the coding sequence of
extracellular domain of P2X2a and P2X2b
subunits was used to facilitate the swapping of the extracellular
sequence flanked by EcoRI and SacI sites. By
using PCR conditions described previously (22), the open reading frames
for P2X2a, P2X2b, and P2X3
receptors were isolated and subcloned into HincII and
SmaI sites of a pBluescript vector (Stratagene, La Jolla,
CA) with the SacI site in the multiple cloning sites
removed. The extracellular domain of the P2X3 subunit (Val60-Phe301) flanked by EcoRI and
SacI sites was excised and used to replace the corresponding
region (Ile66-Tyr310) of P2X2a and
P2X2b subunits. The chimeric constructs of
P2X2a and P2X2b subunits with a
P2X3 subunit extracellular domain were designated as
P2X2a/X3ex and
P2X2b/X3ex, respectively. By using a similar
strategy, the extracellular domain of P2X2 subunit
(Ile66-Tyr310) was also obtained and used to
substitute the corresponding sequence (Val60-Phe301) of P2X3 subunit.
The resulting construct encoding a P2X3 subunit with a
P2X2 subunit extracellular domain was designated as
P2X3/X2ex (Fig. 1).
A series of extracellular chimeric mutants were generated using the
restriction site-independent method as described previously (25).
Briefly, the coding sequences for the extracellular regions of
P2X2a and P2X3 subunits were subcloned into a
pBluescript vector at SacI/EcoRI and
KpnI sites, respectively, in a head-to-tail configuration.
Two µg of the construct carrying two extracellular sequences was
linearized by digesting it with ClaI and XhoI.
The linearized plasmid was then directly used for transformation into competent DH5
Escherichia coli strain (Invitrogen).
During transformation and recovery, processes for chimera formation
involve partial exonuclease digestion of linearized plasmid and base
pairing between exposed ends of two inserts, followed by bacterial
repair to a single sequence and ligation to recircularize the chimera
plasmid (25). Ampicillin-resistant bacterial colonies containing
circular plasmids were screened for a series of chimeric constructs by restriction enzyme digestion and PCR. In these mutant extracellular domains, chimeric junctions were in regions of high sequence
conservation between P2X2a and P2X3 subunits.
The coding sequences of these chimeric constructs were subsequently
confirmed with DNA sequencing using a fluorescence-based sequencing kit
(Amersham Biosciences). For functional expression of chimeric
receptors, the coding sequences were excised by XhaI and
KpnI digestion and subcloned into the eukaryotic expression vector pcDNA 3.1 (Invitrogen). In parallel studies, the coding sequences of the P2X3 receptor and the newly constructed
chimeric receptors were also subcloned into the bicistronic vector
pIRES2-EGFP (Clontech, Palo Alto, CA). These pIRES2
constructs contain the internal ribosome entry site of viral origin for
constitutive expression of GFP. The fluorescence signal of GFP was used
to identify transfected GT1 cells for single cell
[Ca2+]i measurement.
Cell Culturing and Functional Expression Studies--
GT1 cells
were cultured in Dulbecco's modified Eagle's medium and Ham's F-12
medium (1:1), supplemented with 10% fetal calf serum, 100 µg/ml
ampicillin, and 100 µg/ml streptomycin. Transient transfection was
performed as described previously (22) with slight modifications.
Briefly, 1 million GT1 cells were plated on coverslips coated with
poly-L-lysine and allowed to attach for 24 h. On the
day of transfection, 3 µg of the plasmid DNA was mixed with 15 µl
of Plus ReagentTM and 3 µl of LipofectAMINETM
(Invitrogen) in 3 ml of serum-free Opti-MEM medium, incubated for 15 min at room temperature, and then applied to cells. After 3 h of
incubation, the medium was replaced with fresh culture medium. Single
cell Ca2+ recordings were performed 24-48 h after
transfection. In co-transfection experiments, equal amounts of two
expression constructs were used. GT1 cells transfected with pcDNA
3.1 vector without insert did not show any detectable
[Ca2+]i response upon 100 µM ATP application.
Measurements of Ca2+ Ion Concentration--
Single
cell [Ca2+]i measurements were performed as
described previously (22). Briefly, cells were incubated at 37 °C
for 60 min with 2 µM fura-2 AM in phenol red- and
ATP-free medium 199 with Hanks' salt solution, subsequently washed
with assay buffer containing 137 mM NaCl, 5 mM
KCl, 1.2 mM CaCl2, 1 mM
MgCl2, 10 mM HEPES, pH 7.4, and 10 mM glucose, and kept for at least half an hour in this
medium prior to measurements. Apyrase (grade I) was purchased from
Sigma and used at 10 µg/ml throughout the incubation process.
Coverslips with cells were mounted on the stage of an Axiovert 135 microscope (Carl Zeiss, Oberkochen, Germany) attached to the Attofluor
Digital Fluorescence Microscopy System (Atto Instruments, Rockville,
MD). [Ca2+]i responses were examined under a 40×
oil immersion objective during the exposure to alternating 340 and 380 nm light beams, and the intensity of light emission at 520 nm was
measured. The ratio of light intensities,
F340/F380, which reflects
changes in [Ca2+]i, was simultaneously followed
in several single cells. Cells expressing fluorescence protein were
optically detected by an emission signal at 520 nm when excited by 488 nm ultraviolet light and were not detectable by 340 or 380 nm
excitations. In co-transfection experiments with pIRES vectors, about
75% of fluorescent protein-positive cells responded to agonist
stimulation and were considered to be co-transfected. Lower
co-transfection efficiency below this level was excluded from further analysis.
Expression in Xenopus laevis Oocytes and Electrophysiological
Recordings--
Oocytes at stage V and VI were isolated from adult
X. laevis as described previously (26) and placed in
modified Barth's saline (MBS) consisting of 88 mM NaCl, 1 mM KCl, 10 mM HEPES, 0.82 mM
MgSO4, 2.4 mM NaHCO3, 0.91 mM CaCl2, and 0.33 mM
Ca(NO3)2 at pH 7.5. The oocyte nuclei were
directly injected with 1.5 ng of expression constructs for
P2X2a/X3ex or P2X3/X2ex
in 30 nl of injection buffer (88 mM NaCl, 1 mM
KCl, 15 mM HEPES, pH 7.0). Injected oocytes were maintained
for 3 days at 18 °C in sterilized incubation medium containing MBS
plus 10 µg/ml streptomycin, 10 units/ml penicillin, 50 µg/ml
gentamicin, and 2 mM sodium pyruvate. For
electrophysiological recording, oocytes were placed in a rectangular chamber of 100 µl volume and perfused with Ba2+-Ringer's
solution (115 mM NaCl, 2.5 mM KCl, 1.8 mM BaCl2, and 10 mM HEPES, pH 7.4)
at a rate of 2 ml/min. The oocytes were then impaled with two glass
electrodes (0.5-10 megohms) filled with 3 M KCl and
voltage-clamped at
70 mV using OC-725C Oocyte Clamp Amplifier (Warner
Instruments, Inc., Hamden, CT). Currents were digitally recorded with
PowerLab/200 and Chart software (ADInstruments, Grand Junction, CO).
ATP was first dissolved in distilled water and then diluted in
Ba2+-Ringer's solution immediately before use and was
applied for 30 s. All measurements were performed at ambient temperature.
Immunological Detection of Epitope-tagged
P2XRs--
Hemagglutinin (HA) epitope, YPYDVPDYA, was added to the
C-terminal end of P2X2, P2X3, and chimeric
subunits, and FLAG (FL) epitope, DYKDDDDK, was added to the N terminus
of P2X2a and P2X2b. The 5'-primer sites for HA
tagging corresponded to the nucleotide sequence 803-824 of
P2X2a (27) and 525-544 of the P2X3 (17). The
FL epitope was inserted between the initiative methionine residue and
the second amino acid of the P2X2 by PCR. The 5'-primer sequence contained 6 bases of XhoI site, optimized
translational sequence (28), 3 bases for methionine, 24 bases encoding
the 8-amino acid FL-peptide sequence, and 21 bases encoding 7 amino acids next to initiator methionine. The 3'-primer for FL tagging has
nucleotide sequence 541-562 of P2X2a. PCR were performed
using P2X2SE and P2X3SE as templates, and
amplified products were subcloned into pBluescript II vector for
sequencing. Correctly tagged fragments were transferred to expression
constructs using EcoRI/KpnI and XhoI/NarI for C-terminal and N-terminal
substitutions, respectively.
Crude membranes were prepared from GT1 cells 24-48 h after
transfection as follows. Cultured cells in 60-mm dishes were washed once with ice-cold PBS and collected in TE buffer (50 mM
Tris-HCl, pH 7.4, containing 5 mM EDTA, 10 µg/ml
aprotinin, 10 µg/ml leupeptin, and 0.1 mM
phenylmethanesulfonyl fluoride). Cells were homogenized on ice, and
membrane fractions were collected by centrifugation at 10,000 × g for 10 min at 4 °C. The pellets were then lysed in the
TE buffer containing 1% Triton X-100 on ice for 30 min and centrifuged
at 30,000 × g for 30 min. The supernatant and antibody
for immunoprecipitation were incubated for 1 h at 4 °C and
additionally for 2 h with protein G. The immunocomplexes were washed four times with the lysis buffer, denatured, and subjected to
gel electrophoresis. After separation, protein was electrically transferred to polyvinylidene fluoride membranes. The blots were incubated with 3% bovine serum albumin in TBS (10 mM
Tris-HCl, pH 7.5, and 150 mM NaCl) and then with monoclonal
anti-HA antibody (Babco, Richmond, CA) at a dilution of 1:3500 or
anti-FL M2 antibody (Eastman Kodak Co.) at 1:2000 dilution. For
secondary antibody, peroxidase-conjugated anti-mouse antibody was
diluted 1:5000, and signals were visualized with enhanced
chemiluminescence ECL (Amersham Biosciences). Protein concentration in
the membrane protein samples was determined using the Pierce BCA
protein assay (Pierce).
For biotinylation of cell-surface protein, cells were treated with 0.5 mg/ml N-hydroxysulfosuccinimide-LC-biotin (Pierce) in assay
buffer for 30 min at ambient temperature. The reaction was terminated
by washing cells once with assay buffer containing 50 mM
ammonium chloride, followed by two washings with assay buffer only.
Cells were then lysed with TE buffer containing 1% Triton X-100 and
subsequently immunoprecipitated with antibody against epitope.
Biotinylated protein on the membrane was detected by peroxidase-conjugated streptavidin (Amersham Biosciences) at 1:5000 dilutions and visualized.
Photoaffinity Labeling of P2XR--
Cells grown in 60-mm dishes
were transfected with expression constructs for FL-tagged
P2X2a and HA-tagged P2X3 as described above.
Twenty four hours after transfection, cells were washed with ice-cold
phosphate buffer and incubated in assay buffer containing 1 µM [
-32P]8-azido-ATP (370 GBq/mmol, ICN, Costa Mesa, CA) on ice for 10 min. UV irradiation was
performed at 254 nm wavelength with 4 milliwatts/cm2 for 3 min. After washing with phosphate buffer to remove unlabeled ligand,
cells were collected in 0.5 ml of lysis buffer and subjected for
immunoprecipitation with anti-FL antibody. Equal amounts of protein
samples (20 µg) were denatured, loaded onto 7.5% SDS-polyacrylamide gel, and visualized by autoradiography using x-ray film (Eastman Kodak).
Calculations--
Where appropriate, the results were expressed
as means ± S.E. The time course of [Ca2+]i
signaling was fitted to a single exponential function, and
dose-response curves obtained by [Ca2+]i
measurements were fitted to three-parameter logistic function using a
non-linear curve-fitting program (Igor, WaveMetrics, Lake Oswego, OR).
Significant differences were determined by either Student's
t test or one-way analysis of variance followed by
Scheffe's test, if applicable, and p < 0.05 was
considered as significantly different.
 |
RESULTS |
Effect of Extracellular Chimeric Mutations on Agonist
Specificity--
To analyze the importance of extracellular P2XR
domains in calcium signaling, three native subunits, P2X2a,
P2X2b, and P2X3, and two chimeric subunits,
P2X2a/X3ex and
P2X2b/X3ex (Fig.
1), were individually expressed in GT1
cells, and agonist-induced [Ca2+]i responses were
monitored in single cells. As shown in Fig.
2, A and B, 10 µM 
-meATP evoked only a small rise in [Ca2+]i in P2X2aR- and
P2X2bR-expressing cells, whereas the subsequent stimulation
with 100 µM ATP resulted in a rapid and large increase in
[Ca2+]i. The declining rates in
[Ca2+]i toward steady levels were faster in
P2X2bR-expressing cells than in cells expressing
P2X2aR. The differences in the macroscopic channel kinetics
judged from these single cell [Ca2+]i
recordings correlate well with the structural differences of the
putative C-terminal regions and are in accord with previously published
data (21) using [Ca2+]i and current
measurements.

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 1.
Schematic representation of extracellular
chimeric P2XR subunits. The putative extracellular regions
Val60 to Phe300 of P2X3 and
Ile66 to Tyr310 of P2X2 were
mutually exchanged to make extracellular chimeric subunits termed
P2X2a/X3ex, P2X2b/X3ex,
and P2X3/X2ex. The difference between
P2X2a and P2X2b is in the C-terminal region,
where P2X2b lacks a stretch of 69 amino acids achieved by
an alternative splicing reaction. In
P2X2a/X3V60-R180, the
N-terminal half of the P2X3 extracellular region was
transferred to the equivalent part of P2X2a
subunit.
|
|

View larger version (13K):
[in this window]
[in a new window]
|
Fig. 2.
Sequential stimulation of P2X2aR,
P2X2bR, and P2X3R by
 -meATP and ATP. Transfected
cells were optically identified by the GFP-derived fluorescence
signals, and P2X2aR (A), P2X2bR
(B), and P2X3R (C) were stimulated by
the sequential application of 10 µM  -meATP and 100 µM ATP. In this and the following figures, each trace
represents the mean value from five to eight single cell recordings,
and experiments were repeated in three to six preparations. Dye-loading
solutions with (filled circles) or without (open
circles) 10 µg/ml apyrase were indicated at the end of the
recordings.
|
|
In contrast to P2X2R-expressing cells, ATP and 
-meATP
were unable to elevate the [Ca2+]i in
P2X3R-expressing cells when recordings were done under
identical experimental conditions. Because neurons frequently secrete
ATP, which in turn could desensitize P2XRs, we evaluated this
hypothesis by preincubating GT1 cells with 10 µg/ml apyrase, an
ecto-ATPase (22). After the incubation with apyrase, stimulation of
P2X3Rs with 10 µM 
-meATP resulted in a
rapid and transient increase in [Ca2+]i (Fig.
2C) (n = 118). To fully regain agonist
responsiveness in P2X3R-expressing cells, incubation in
ecto-ATPase containing buffer was necessary for at least 20 min. On the
other hand, this pretreatment had no apparent effect on
P2X2aR and P2X2bR desensitization rates (Fig.
2, A and B).
The intrinsic characteristics of P2X3Rs, high
sensitivity to 
-meATP and rapid desensitization, were assessed in
two extracellular chimeric receptors,
P2X2a/X3ex and
P2X2b/X3ex, in which the extracellular region
of P2X3 subunit was transferred to the analogous parts of
P2X2a and P2X2b subunits (Fig. 1). When
expressed as homomeric channels, both chimeric receptors responded to
application of 10 µM 
-meATP with a rapid increase
in [Ca2+]i, but only after preincubating cells
with apyrase (Fig. 3, filled
circles versus open circles). In GFP-positive cells transfected with P2X2a/X3ex or
P2X2b/X3ex, 92 (n = 65) and
86% (n = 76) of the cells also responded to ATP,
respectively, whereas no apparent increase in
[Ca2+]i was observed in both cell types without
apyrase treatment (82 cells with P2X2a/X3ex and
68 cells with P2X2b/X3ex). Therefore, we
considered that these two P2X3R-specific characters are
largely dependent on the structure of the ectodomain and could be
transferred to the extracellular mutants when expressed as homomeric
channels.

View larger version (21K):
[in this window]
[in a new window]
|
Fig. 3.
Apyrase and
 -meATP sensitivity of chimeric
P2XR. Cells expressing P2X2a/X3ex and
P2X2b/X3ex subunits were stimulated with 10 µM  -meATP after 1 h of preincubation with
apyrase (filled circles) or solvent (open
circles).
|
|
The desensitization rate of [Ca2+]i signals
induced by ATP was significantly accelerated in chimeric receptors
compared with native P2X2aRs and P2X2bRs (Fig.
4A). The calculated time constants of signal desensitization from these measurements were as
follows (in 10
3/s): 4 ± 0.17 versus
12 ± 1.3 for P2X2aRs (n = 41) and
P2X2a/X3ex (n = 40),
respectively, and 20 ± 2.0 versus 23 ± 7.1 for
P2X2bRs (n = 37) and
P2X2b/X3ex (n = 47),
respectively (Fig. 4B). Although the desensitization rates
for both mutant receptors significantly increased by the substitution
of extracellular region in P2X2 subunits, this modification
alone was not sufficient to mimic the rapid desensitization rate of
homomeric P2X3Rs. This suggests that the other subunit
domains, including the transmembrane domains and the C terminus, may
also participate in desensitization, as already suggested (21, 29, 30).
Notably, the modulatory effects of C-terminal splicing and
extracellular chimeric mutation on the rate of receptor desensitization
were additive; both C-terminal splicing and transfer of extracellular
domain increased the desensitization rate seen in
P2X2b/X3ex-expressing cells.

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 4.
Desensitization patterns of homomeric
channels during continuous stimulation with 100 µM ATP. A, the declining
phase of [Ca2+]i signals was fitted to a single
exponential decay curve. B, the time constants (in
10 3/s) of signal decay were calculated from three to five
experiments performed with at least 15 cells in each measurement. *,
p < 0.05, when wild-type and extracellular mutant were
compared.
|
|
Effects of Extracellular and C-terminal Domains on Heteromeric
Channel Functions--
In general, functional P2X channels are formed
by homomeric and heteromeric multimerization, depending on subunits
expressed in single cells. In further experiments, we used receptors in heteromultimeric configurations to investigate the interactive effects
of extracellular and intracellular domains on agonist potency and
receptor desensitization. Co-expression of wild-type P2X2a
and chimeric P2X2a/X3ex subunits in single
cells increased sensitivity to 
-meATP compared with the cells
expressing homomeric P2X2aRs (Figs. 2A and
5A). Furthermore, in contrast to homomeric P2X2a/X3exRs, 10 µM

-meATP-induced [Ca2+]i response by
heteromeric P2X2a/X3ex + P2X2a
receptors was not dependent on preincubation of cells with apyrase.
Because [Ca2+]i responses induced by 10 µM 
-meATP were small in cells expressing homomeric
P2X2a and not detectable in cells expressing homomeric
P2X3R when incubated without apyrase, it was reasonable to
conclude that a newly developed feature of 
-meATP-sensitive but
apyrase-insensitive [Ca2+]i response in
co-transfected cells was largely due to activation of heteromeric channels.
We also compared the pattern of 
-meATP-induced
[Ca2+]i signaling in co-transfected cells with
different sets of wild-type and chimeric subunits (Fig.
5A). Heteromeric
P2X2a + P2X2a/X3ex receptors showed
slow desensitization, whereas the channels formed by P2X2b + P2X2b/X3ex subunits desensitized in a
remarkably strong manner (Fig. 5B). Physical associations
between chimeric and naturally occurring P2X2 subunits were
confirmed using a co-immunoprecipitation method (Fig. 5C).
In this and following experiments, the immunological detection of
channel molecule was done using the epitope-tagged subunits at either
the N or C terminus, a procedure that had no significant effect on
agonist-induced [Ca2+]i (Table
I) and current (31) responses. The
calculated molecular weight of P2X subunit monomers from Western blot
was consistently larger than predicted from the polypeptide sequence. For example, P2X2a and P2X2b subunit resulted
in 70- and 59-kDa bands (Fig. 5, C-E), whereas the expected
mass was 53 and 45 kDa, respectively. Thus, P2XR subunits
expressed in GT1 cells were considered to undergo extensive
glycosylation during their post-translational process.

View larger version (46K):
[in this window]
[in a new window]
|
Fig. 5.
Co-expression of P2X2 and
chimeric subunits. A, equal amounts of the expression
constructs for wild-type and extracellular chimeric subunits were used
for each transfection. Cells expressing P2X2a
(upper) and P2X2b (lower) subunits
together with the corresponding chimeric mutants were stimulated with
10 µM  -meATP (open triangles) and
subsequently with 100 µM ATP (arrows). In this
experiment, cells were not treated with apyrase. B,
calculated time constants for desensitization of heteromeric channels.
Decay curve of 10 µM  -meATP-induced
[Ca2+]i signals was fitted to single exponential
function, and time constants were calculated. Significant differences
of desensitization rates between cells co-expressing P2X2a + P2X2a/X3ex and each one of the other
transformants were indicated as * (p < 0.05) and **
(p < 0.01). C, heteromeric assembly of
P2X2 and chimeric subunits. Cells co-transfected with
FL-tagged P2X2 subunits and HA-tagged mutant subunits were
co-immunoprecipitated with anti-FL antibody, and blots were probed with
anti-HA (upper panel) and anti-FL (lower panel)
antibodies. D, heteromeric assembly of P2X2a and
P2X2b subunits. FL-tagged P2X2a was
co-expressed with HA-tagged P2X2a or P2X2b
subunits. Cell lysates was subjected to immunoprecipitation with
anti-FL antibody, and blot was probed with anti-HA (upper
panel) and anti-FL (lower panel) antibodies.
E, homo- and heteromeric assembly of P2X2
subunits located in the plasma membrane. GT1 cells expressing
tagged-P2X subunits were treated with plasma membrane-impermeable
biotinylation reagents, immunoprecipitated with anti-FL antibody,
separated on SDS-PAGE, blotted onto polyvinylidene difluoride membrane,
and probed with peroxidase-conjugated streptavidin. Kd,
molecular mass markers.
|
|
View this table:
[in this window]
[in a new window]
|
Table I
Functional characters of wild-type and epitope tagged P2XRs
P2XRs expressed in GT1 cells were stimulated with different
concentrations of ATP, and peak [Ca2+]i values were
plotted against ATP concentrations. Each point in the dose-response
curves for [Ca2+]i measurements was derived from
11-64 single cells, and the curves were then fitted to a
three-parameter logistic equation with a non-linear fitting method as
described under "Experimental Procedures." Additions of either HA
or FLAG epitope to the N or C termini of P2XR subunits had no
significant effect on the channel characters. The data shown are the
mean ± S.E. from three to five experiments. Amplitude in
F340/F380 ratio, the maximum
increase in [Ca2+]i; Hill's coeff.
(nH), Hill's coefficients; and EC50,
EC50 values in µM.
|
|
Both mutations, at the extracellular regions and C-terminal domain, did
not perturb association between wild-type and chimeric P2X2
subunits (Fig. 5C), as suggested previously (32). The actual association between P2X2a and P2X2b subunits
was also confirmed (Fig. 5D) and possibly occurred at the
plasma membrane, because the subunits consisting of cell-surface
receptors were modified with the plasma membrane-impermeable
biotinylation reagents and were co-immunoprecipitated (Fig.
5E). These results suggest that in cells expressing
P2X2a and P2X2b subunits, pituitary
somatotrophs for example (10), their heteromultimeric association could
generate a functional channel that desensitizes faster than the
homomeric P2X2aRs.
Localization of 
-meATP and Apyrase Sensitivities within the
Ectodomain of P2X3 Subunit--
To identify the regions in
the extracellular domain of P2X3 subunit responsible for

-meATP and apyrase sensitivities, a series of extracellular
chimeras between P2X3 and P2X2a subunits were
prepared. The following amino acid regions of P2X2a were replaced to the corresponding extracellular parts of P2X3:
66-82, 66-101, 66-192, 66-273, 66-296, 98-310, 159-310,
192-310, 274-310, and 295-310. When expressed in GT1 cells
individually or together with P2X2a, however, all these
mutant receptors were not functional except one, termed
P2X2a/X3V60-R180, in
which the Ile66 to His192
sequence of P2X2a was replaced with Val60 to
Arg180 sequence of P2X3 (Fig. 1). Cells
expressing this particular mutant responded to 10 µM

-meATP with a rapid increase in [Ca2+]i and
slow desensitization, similar to those observed in
P2X2aR-expressing cells stimulated by ATP (Fig.
6). Furthermore, agonist-induced
[Ca2+]i response was not dependent on
preincubation with apyrase (Fig. 6). Therefore, the two specific
features of P2X3Rs, 
-meATP sensitivity and
apyrase-dependent recovery from desensitization, are
separately localized to their responsible extracellular regions; the
N-terminal half of the extracellular loop accounts for high potency of

-meATP and the C-terminal half for recovery from desensitization.

View larger version (15K):
[in this window]
[in a new window]
|
Fig. 6.
Agonist-specific pattern of
[Ca2+]i response in
P2X2a/X3V60-R180-expressing
cells. The apyrase pretreatment was not required for
 -meATP-induced [Ca2+]i response in cells
expressing homomeric
P2X2a/X3V60-R180
channels. The sequential stimulations using 10 µM
 -meATP and 100 µM ATP were performed to access
relative potency of two agonists in indicated dosages.
|
|
Restoration of Ca2+ Signaling Function by
Heteromultimerization of Extracellular Mutants--
The effect of
mutual substitution at the extracellular region was further examined
using P2X3/X2ex subunits, in which
extracellular loop of P2X2 subunit was transferred to the
equivalent region of P2X3 (Fig. 1). When expressed in
X. laevis oocytes, mutant P2X3/X2ex
subunits formed a rapidly desensitizing channel (Fig. 7A). However, the amplitude of
ATP-induced inward current was less than half compared with that of
P2X2a/X3ex. The functional expression of
channels was always less successful in
P2X3/X2ex compared with
P2X2a/X3ex. In GT1 cells transfected with
P2X3/X2ex subunit,
[Ca2+]i response was not detectable in
GFP-positive cells (n = 91), although the amount of
subunit protein expressed was comparable with that of
P2X2a/X3ex. Furthermore, the fluorescent signal
from HA-tagged subunit was detected from plasma membrane in
immunohistochemical studies, indicating cell-surface localization of
the subunit (not shown).

View larger version (21K):
[in this window]
[in a new window]
|
Fig. 7.
Characterization of agonist-induced current
and [Ca2+]i signals in cells co-expressing
extracellular mutants. A, Xenopus oocytes
expressing P2X2a/X3ex (left trace)
and P2X3/X2ex subunit (right trace)
demonstrate inward current upon the application of 100 µM
ATP for 30 s. B, HA-tagged
P2X2a/X3ex and
P2X2b/X3ex subunits were co-expressed with
FL-tagged P2X3/X2ex and immunoprecipitated with
an anti-FL antibody and probed with an anti-HA antibody. Kd,
molecular mass markers. C, the
P2X3/X2ex subunit was co-transfected into GT1
cells together with P2X2a/X3ex subunit
(n = 32), P2X2b/X3ex
(n = 48), or empty vector (n = 50) and
sequentially stimulated with 20 µM  -meATP and 100 µM ATP. Representative tracings were presented from
average of five to nine single cell responses from five separate
experiments.
|
|
When both chimeric subunits were co-transfected, a new pattern of
[Ca2+]i signaling was observed. Stimulation of
the co-transfected cells with 20 µM 
-meATP resulted
in full receptor activation that was independent of apyrase
pretreatment, and the subsequent application of 100 µM
ATP was ineffective (Fig. 7C). Therefore, the co-expression
of two extracellular chimeras, P2X2a/X3ex and P2X3/X2ex, resulted in
[Ca2+]i signals similar to those of
heteromultimeric P2X2 and P2X3 channels (17,
18). In addition, the subunits with spliced C termini accelerated the
desensitization rates in heteromeric channels formed by
P2X2b/X3ex + P2X3/X2ex
(Fig. 7, B and C) and by P2X2b + P2X3 (Fig. 8A). As
shown in Fig. 8, B and C, the biotinylated subunits were co-immunoprecipitated from cell lysate, indicating physical associations between P2X3 and either
P2X2a or P2X2b at the cell surface.

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 8.
Heteromeric assembly of P2X2 and
P2X3 subunits. A, the P2X3
subunit was co-expressed with either P2X2a or
P2X2b subunit, and cells were stimulated with 10 µM  -meATP. Decay curves of the
[Ca2+]i signaling were fitted to single
exponential function. Horizontal bars show the calculated
time constants (in 10 3/s). *, p < 0.05. B, HA-tagged P2X3 subunit was
co-immunoprecipitated with FL-tagged full-length or spliced
P2X2 subunits, and blots were probed with anti-HA
(upper) and anti-FL (lower) antibodies.
C, co-immunoprecipitation of cell surface P2X2
and P2X3 subunits. GT1 cells co-expressing
FL-tagged-P2X2 and HA-tagged P2X3 subunits were
treated with amine-reactive and plasma membrane-impermeable
biotinylation reagents, immunoprecipitated with the anti-FL antibody,
separated on SDS-PAGE, blotted, and probed with peroxidase-conjugated
streptavidin. Kd, molecular mass markers.
|
|
Photoaffinity Cross-linking of P2XR by
[
-32P]8-Azido-ATP--
In further experiments,
we characterized agonist potency of 8-azido-ATP and its ability to
label recombinant P2XRs by photoaffinity cross-linking. When stimulated
with equimolar (100 µM) concentration, P2X3R-expressing cells showed preference for 8-azido-ATP
over ATP, whereas P2X2aR-expressing cells showed the
opposite preference (Fig. 9A).
In cells co-transfected with P2X2aR and P2X3R,
application of 10 µM 8-azido-ATP without apyrase
treatment resulted in no detectable changes in
[Ca2+]i, and the subsequent application of 10 µM 
-meATP induced a rapid and large
[Ca2+]i response (Fig. 9B). These
results indicate that 8-azido-ATP is a preferred agonist for homomeric
P2X3Rs over heteromeric channels formed by the
P2X2a and P2X3 subunits, although 
-meATP
effectively activates both channels.

View larger version (14K):
[in this window]
[in a new window]
|
Fig. 9.
Agonist activity of and photoaffinity
labeling by 8-azido-ATP in P2XR-expressing cell. A,
cells expressing P2X3Rs (upper trace) and
P2X2aRs (lower trace) were stimulated with 100 µM 8-azido-ATP (arrows) and 100 µM ATP (open triangles) after preincubation
with apyrase. B, cells co-expressing P2X2a and
P2X3 subunits were stimulated with 10 µM
8-azido-ATP (arrows), 10 µM  -meATP
(filled triangles), and 100 µM ATP (open
triangles). In this experiment, cells were not treated with
apyrase. C, FL-tagged P2X2a and HA-tagged
P2X3 subunits expressed were subjected to photoaffinity
labeling with [ -32P]8-azido-ATP as described
under "Experimental Procedures." Notice that homomeric
P2X3Rs were efficiently labeled, whereas homomeric
P2X2aRs or heteromeric channels were less efficient
substrates for labeling.
|
|
This property of 8-azido-ATP was further confirmed by the effective
photoaffinity labeling of P2X3Rs (Fig. 9C).
Interestingly, in cells co-transfected with P2X2a and
P2X3, P2X3 subunits joining a heteromeric
channel and co-immunoprecipitated with P2X2a, as shown in
Fig. 7B, were not labeled efficiently with
[
-32P]8-azido-ATP compared with the signal from
homomeric P2X3 subunits (Fig. 9C). This
indicates that 8-azido-ATP can distinguish conformation of the
ATP-binding pocket formed by homomeric P2X3Rs from those formed by heteromeric P2X2a + P2X3 receptors.
Preincubation of cells with 100-fold excess concentration of ATP
resulted in a total inhibition of photolabeling (data not shown).
 |
DISCUSSION |
In this study, we evaluated the combined effects of structural
changes introduced into the extracellular and C-terminal regions of the
P2XR subunit on agonist selectivity, receptor desensitization, and
recovery from desensitization. ATP is a common agonist for all
homomeric and heteromeric P2XRs, and modification at the triphosphate moiety of this molecule serves as an important determinant for P2X
subtype selectivity. The substitution of bridging oxygen between
-
and
-phosphorous with a methylene group resulted in an agonist (
-meATP) that is equipotent for ATP for P2X3R and
P2X1R and practically ineffective for other channels. On
the other hand, modification in the 2'- and 3'-positions of ribose in
trinitrophenyl-ATP made a selective antagonist against these subunits
(33). High sensitivity of P2X3R to 
-meATP can be
transferred to P2X2aRs and P2X2bRs by
generating the extracellular chimeras. Therefore, the responsible
counterpart in P2X3 subunit that functionally interacts
with the polyphosphate chain in ATP is of importance for understanding
the structure-activity relationship between ligand and receptor. We
found that the N-terminal half of P2X3 ectodomain, from
Val60 to Arg180, was necessary for receptor
activation by 
-meATP. The attempt to further narrow this region
was hampered, presumably due to highly vulnerable feature of
extracellular domains to modification by site-directed mutations. Thus,
despite the conserved amino acid sequences in the extracellular domains
of P2XR subunits, agonist potency is highly susceptible to subtle
structural modifications.
In addition to altered preference for agonists, the desensitization
rates were significantly accelerated in chimeric P2XRs. A comparison of
time constants for desensitization between chimeric and wild-type
P2X2Rs revealed that extracellular substitution and
C-terminal splicing at P2X2 subunit had additive effects. Among the subunits examined, the P2X2b/X3ex
channel showed the strongest and wild-type P2X2a the
weakest desensitization. Therefore, extracellular and C-terminal
domains might have separate molecular mechanisms for controlling the
desensitization rate. Furthermore, the rate of
P2X2b/X3ex desensitization did not reach that
of native P2X3Rs. As shown previously (23, 29), the
pore-forming transmembrane domain and the cytoplasmic N terminus of
P2X2aRs also contributed to the desensitization process. In
particular, the N-terminally located Thr18 in the consensus
sequence for phosphorylation by protein kinase C is constitutively
phosphorylated in P2X2aRs, and removal of this residue by
site-directed mutagenesis converted a lasting receptor activity to fast
desensitization. Therefore, intracellular events, in addition to
primary structure of P2X subunits, can influence the desensitization
process. The summation of modulatory effects from each subdomain can
also determine the rate of receptor desensitization and the duration of
P2XR-derived currents and [Ca2+]i signals.
The somatotroph population of secretory anterior pituitary cells
expresses both P2X2a and P2X2b subunits (10,
34, 35). The P2X2b subunits form homomeric channels, which
desensitize faster than P2X2aRs. Reducing the amount of
mRNA available for full-length P2X2a by splicing is
probably one of the mechanisms by which cells limit the number of
mature P2X2aRs and thus the excessive Ca2+
entry during receptor activation. The other post-transcriptional mechanism to achieve the same goal is heteromultimerization of P2X2a and P2X2b subunits. Because homomeric and
heteromeric P2X2Rs are indistinguishable from each other in
pharmacological terms and both channels are present in single cells, it
is difficult to quantitate the effect of spliced C terminus through the
pattern of Ca2+ influx.
Here we used the extracellular region of the 
-meATP-sensitive
P2X3 as a marker for studies on the impact of
heteromultimerization on [Ca2+]i signaling
pattern. A series of heteromers formed between wild-type and
extracellular chimeric subunits enabled us to quantitate the
contribution of spliced C terminus to the desensitization rates of
receptors in heteromeric configuration. As the number of subunits with
spliced C termini increases in co-transfection experiments, the

-meATP-induced [Ca2+]i signals became
shorter (Fig. 5, A and B). Therefore, it is
likely that heteromers formed by P2X2a and
P2X2b would desensitize faster than homomeric
P2X2aRs and slower than homomeric P2X2bRs. The
actual association of these two isoform subunits in the plasma membrane
was also demonstrated.
The transfer of P2X2 extracellular domain to the
corresponding part of P2X3 resulted in
P2X3/X2ex subunits that were less efficiently
expressed as homomeric channels. However, the heteromers between two
chimeric subunits, in which the extracellular domains were mutually
exchanged, regained agonist sensitivity and preference to 
-meATP.
Such heteromers desensitized with moderate rates and rapidly recovered
from desensitization, as judged from responsiveness independent of
ecto-ATPase treatment. These new characters of heteromeric
P2X2a/X3ex and
P2X3/X2ex channels were similar to those of the
naturally occurring heteromeric channel between P2X2a and
P2X3. Interestingly, the pore-forming transmembrane domains of mutant heteromers are exactly same as that of naturally occurring heteromers between P2X2a and P2X3, whereas
relative positions of the 
-meATP-sensitive extracellular domains
to the transmembrane region were exchanged. We may speculate that the
effect of 
-meATP stimulation, leading to the allosteric
conformational change required for activation and desensitization of
channels, might pursue the same course in heteromeric channels made by
P2X3 + P2X2a and by P2X2a/X3ex + P2X3/X2ex.
Our results indicate that heteromeric channels can be composed from any
combinations of two subunits among P2X2a,
P2X2b, and P2X3 when expressed in a single cell
and can exhibit particular desensitization kinetics determined by the
nature of participating subunits. In accordance with this,
P2X2a and P2X3 subunits are also able to form
functional heteromers in small diameter sensory neurons (17, 18). As
shown here, the C-terminal splicing of P2X2 did not affect
the ability of this subunit to form heteromers with P2X3 or
P2X2a. Pituitary cells express comparable levels of
P2X2a and P2X2b transcripts, and the
calcium-signaling pattern by native channels resembles that observed in
cells co-transfected with P2X2a and P2X2b (10).
On the other hand, the transcripts for P2X2b subunit
produced in human spinal cord are hardly detectable by RT-PCR analysis
(36) and at the level of detection in rat dorsal root ganglion (12),
indicating that not all cells use C-terminal splicing leading to
heteromeric channels.
In heteromeric configuration, the contribution of P2X3
subunit to the ATP-binding pocket seems different from that in
homomeric channels. We demonstrated efficient photoaffinity labeling of homomeric P2X3 channels by radiolabeled 8-azido-ATP.
Because 8-azido-ATP is an agonist for P2X3Rs, photoaffinity
labeled channels are likely to be in a desensitized state. Agonist
potency examined in single cell [Ca2+]i
measurements indicated that preincubation of 10 µM 8-azido-ATP with cells expressing heteromeric P2X2a and
P2X3 channels did not alter the apparent amplitude induced
by 
-meATP. These results suggested that heteromeric channels did
not undergo detectable levels of desensitization during incubation with
10 µM 8-azido-ATP. Therefore, it is likely that
8-azido-ATP can detect structural differences at the ATP-binding
pockets formed by the homomeric and heteromeric channels.
In summary, the extracellular domain of P2X3 and the
spliced C terminus of P2X2b can additively accelerate
channel desensitization when these subunits form heteromeric channels.
The relative position of these two modulatory receptor domains to the
cation-permeable pore formed by transmembrane domains is exchangeable
between channel-forming subunits, suggesting a symmetrical
configuration of subunits around the pore. In cells expressing
wild-type and spliced P2X2 subunits together, regulated
Ca2+ influx is accomplished by the two kinds of
post-transcriptional modification mechanisms, C-terminal splicing and
heteromeric assembly between full-length and spliced subunits. Channel
function can be further regulated by phosphorylation and alteration of
receptor localization. The consequence of more than one regulatory
factor present at same time seems to be a subject for the future P2XR studies.
 |
ACKNOWLEDGEMENT |
We thank Dr. Melanija Tomic for initial
[Ca2+]i measurements.
 |
FOOTNOTES |
*
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
Supported by Japan Health Sciences Foundation.
**
To whom correspondence should be addressed: Dept. of Molecular,
Cell Pharmacology, National Research Institute for Child Health and
Development, 3-35-31, Taishido, Setagaya-Ku, Tokyo 154, Japan. Tel.:
81-3-3419-2476; Fax: 81-3-3419-1252; E-mail:
gtsujimoto@nch.go.jp.
Published, JBC Papers in Press, October 1, 2002, DOI 10.1074/jbc.M205274200
 |
ABBREVIATIONS |
The abbreviations used are:
P2XRs, ligand-gated
purinergic receptor-channels;

-meATP, 
-methylene ATP;
GFP, green fluorescent protein;
HA, hemagglutinin;
[Ca2+]i, intracellular free calcium
concentration: FL, FLAG.
 |
REFERENCES |
| 1.
|
Burnstock, G.
(1990)
Ann. N. Y. Acad. Sci.
603,
1-17[Medline]
[Order article via Infotrieve]
|
| 2.
|
Ralevic, V.,
and Burnstock, G.
(1998)
Pharmacol. Rev.
50,
413-492[Abstract/Free Full Text]
|
| 3.
|
Edwards, F. A.,
Gibb, A. J.,
and Colquhoun, D.
(1992)
Nature
359,
144-147[CrossRef][Medline]
[Order article via Infotrieve]
|
| 4.
|
Warland, J. J.,
and Burnstock, G.
(1987)
Br. J. Pharmacol.
92,
871-880[Medline]
[Order article via Infotrieve]
|
| 5.
|
Tomic, M.,
Jobin, R. M.,
Vergara, L. A.,
and Stojilkovic, S. S.
(1996)
J. Biol. Chem.
271,
21200-21208[Abstract/Free Full Text]
|
| 6.
|
Di Virgilio, F.,
Borea, P. A.,
and Illes, P.
(2001)
Trends Pharmacol. Sci.
22,
5-7[Medline]
[Order article via Infotrieve]
|
| 7.
|
Bean, B. P.
(1992)
Trends Pharmacol. Sci.
13,
87-90[CrossRef][Medline]
[Order article via Infotrieve]
|
| 8.
|
Radford, K. M.,
Virginio, C.,
Surprenant, A.,
North, R. A.,
and Kawashima, E.
(1997)
J. Neurosci.
17,
6529-6533[Abstract/Free Full Text]
|
| 9.
|
North, R. A.,
and Surprenant, A.
(2000)
Annu. Rev. Pharmacol. Toxicol.
40,
563-580[CrossRef][Medline]
[Order article via Infotrieve]
|
| 10.
|
Koshimizu, T.,
Tomic, M.,
Van Goor, F.,
and Stojilkovic, S. S.
(1998)
Mol. Endocrinol.
12,
901-913[Abstract/Free Full Text]
|
| 11.
|
Brandle, U.,
Spielmanns, P.,
Osteroth, R.,
Sim, J.,
Surprenant, A.,
Buell, G.,
Ruppersberg, J. P.,
Plinkert, P. K.,
Zenner, H. P.,
and Glowatzki, E.
(1997)
FEBS Lett.
404,
294-298[CrossRef][Medline]
[Order article via Infotrieve]
|
| 12.
|
Simon, J.,
Kidd, E. J.,
Smith, F. M.,
Chessell, I. P.,
Murrell-Lagnado, R.,
Humphrey, P. P.,
and Barnard, E. A.
(1997)
Mol. Pharmacol.
52,
237-248[Abstract/Free Full Text]
|
| 13.
|
Khakh, B. S.,
Burnstock, G.,
Kennedy, C.,
King, B. F.,
North, R. A.,
Seguela, P.,
Voigt, M.,
and Humphrey, P. P.
(2001)
Pharmacol. Rev.
53,
107-118[Abstract/Free Full Text]
|
| 14.
|
Ennion, S.,
Hagan, S.,
and Evans, R. J.
(2000)
J. Biol. Chem.
275,
29361-29367[Abstract/Free Full Text]
|
| 15.
|
Jiang, L. H.,
Rassendren, F.,
Surprenant, A.,
and North, R. A.
(2000)
J. Biol. Chem.
275,
34190-34196[Abstract/Free Full Text]
|
| 16.
|
Koshimizu, T.,
Van Goor, F.,
Tomic, M.,
Wong, A. O.,
Tanoue, A.,
Tsujimoto, G.,
and Stojilkovic, S. S.
(2000)
Mol. Pharmacol.
58,
936-945[Abstract/Free Full Text]
|
| 17.
|
Lewis, C.,
Neidhart, S.,
Holy, C.,
North, R. A.,
Buell, G.,
and Surprenant, A.
(1995)
Nature
377,
432-435[CrossRef][Medline]
[Order article via Infotrieve]
|
| 18.
|
Chen, C. C.,
Akopian, A. N.,
Sivilotti, L.,
Colquhoun, D.,
Burnstock, G.,
and Wood, J. N.
(1995)
Nature
377,
428-431[CrossRef][Medline]
[Order article via Infotrieve]
|
| 19.
|
Le, K. T.,
Babinski, K.,
and Seguela, P.
(1998)
J. Neurosci.
18,
7152-7159[Abstract/Free Full Text]
|
| 20.
|
Torres, G. E.,
Haines, W. R.,
Egan, T. M.,
and Voigt, M. M.
(1998)
Mol. Pharmacol.
54,
989-993[Abstract/Free Full Text]
|
| 21.
|
Koshimizu, T.,
Tomic, M.,
Koshimizu, M.,
and Stojilkovic, S. S.
(1998)
J. Biol. Chem.
273,
12853-12857[Abstract/Free Full Text]
|
| 22.
|
Koshimizu, T.,
Koshimizu, M.,
and Stojilkovic, S. S.
(1999)
J. Biol. Chem.
274,
37651-37657[Abstract/Free Full Text]
|
| 23.
|
Boue-Grabot, E.,
Archambault, V.,
and Seguela, P.
(2000)
J. Biol. Chem.
275,
10190-10195[Abstract/Free Full Text]
|
| 24.
|
Horton, R. M.,
Hunt, H. D., Ho, S. N.,
Pullen, J. K.,
and Pease, L. R.
(1989)
Gene (Amst.)
77,
61-68[CrossRef][Medline]
[Order article via Infotrieve]
|
| 25.
|
Buck, K. J.,
and Amara, S. G.
(1998)
Methods Enzymol.
296,
466-475[Medline]
[Order article via Infotrieve]
|
| 26.
|
Beckstead, M. J.,
Weiner, J. L.,
Eger, E. I., II,
Gong, D. H.,
and Mihic, S. J.
(2000)
Mol. Pharmacol.
57,
1199-1205[Abstract/Free Full Text]
|
| 27.
|
Brake, A. J.,
Wagenbach, M. J.,
and Julius, D.
(1994)
Nature
371,
519-523[CrossRef][Medline]
[Order article via Infotrieve]
|
| 28.
|
Kozak, M.
(1991)
J. Cell Biol.
115,
887-903[Abstract/Free Full Text]
|
| 29.
|
Werner, P.,
Seward, E. P.,
Buell, G. N.,
and North, R. A.
(1996)
Proc. Natl. Acad. Sci. U |